World's Best Scientists 2026 revealed!
Peter Vandenberghe

Peter Vandenberghe

D-Index & Metrics

Medicine

D-Index
84
Citations
31319
World Ranking
14946
National Ranking
190

Overview

Peter Vandenberghe is affiliated with KU Leuven in Belgium and has established a research profile focused on Medicine, with significant contributions intersecting Biochemistry, Genetics, and Molecular Biology. Their work spans key subfields such as Oncology, Pathology and Forensic Medicine, Genetics, Hematology, and Immunology.

Their research addresses several main topics, including:

  • CAR-T cell therapy research
  • Cancer Genomics and Diagnostics
  • Lymphoma Diagnosis and Treatment
  • Genetic factors in colorectal cancer
  • Chronic Myeloid Leukemia Treatments
  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia research

Vandenberghe's recent published papers illustrate a progression of work in immuno-oncology, hematological malignancies, and diagnostic criteria in hematology. These papers include:

  • "Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma," 2021, New England Journal of Medicine
  • "Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology," 2020, OncoImmunology
  • "Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes," 2022, Allergy
  • "The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants," 2020, Nature Communications
  • "Comprehensive genome-wide analysis of routine non-invasive test data allows cancer prediction: A single-center retrospective analysis of over 85,000 pregnancies," 2021, EClinicalMedicine

The venues where Vandenberghe frequently publishes include:

  • Blood
  • Nature Communications
  • Cancer Immunology Immunotherapy
  • British Journal of Haematology
  • bioRxiv (Cold Spring Harbor Laboratory)

Vandenberghe often collaborates with several co-authors, reflecting a collaborative research environment. Frequent co-authors include:

  • Thomas Tousseyn
  • Joris Vermeesch
  • Lucienne Michaux
  • Barbara Dewaele
  • Lieselot Buedts

Best Publications

  • Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.

    Ross L. Levine;Ross L. Levine;Martha Wadleigh;Jan Cools;Benjamin L. Ebert;Benjamin L. Ebert

  • A Tyrosine Kinase Created by Fusion of the PDGFRA and FIP1L1 Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome

    Jan Cools;Jan Cools;Daniel J. DeAngelo;Jason Gotlib;Elizabeth H. Stover

  • Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes

    Gorica Nikoloski;Saskia M C Langemeijer;Roland P Kuiper;Ruth Knops

  • Acquired mutations in TET2 are common in myelodysplastic syndromes

    Saskia M C Langemeijer;Roland P Kuiper;Marieke Berends;Ruth Knops

  • Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes.

    Peter Valent;Amy D. Klion;Hans-Peter Horny;Florence Roufosse

  • Autopsy-Controlled Prospective Evaluation of Serial Screening for Circulating Galactomannan by a Sandwich Enzyme-Linked Immunosorbent Assay for Hematological Patients at Risk for Invasive Aspergillosis

    Johan Maertens;Jan Verhaegen;Hilde Demuynck;Penelope Brock

  • Early restaging positron emission tomography with 18F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin’s lymphoma

    K. Spaepen;S. Stroobants;P. Dupont;P. Vandenberghe

  • Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18f]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma : Is [18F]FDG-PET a valid alternative to conventional diagnostic methods?

    Karoline Spaepen;Sigrid Stroobants;Patrick Dupont;Steven Van Steenweghen

  • Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia

    C Graux;Jan Cools;C Melotte;H Quentmeier

  • Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study

    Sylvain Choquet;Veronique Leblond;Raoul Herbrecht;Gérard Socié

  • Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia

    Koenraad Devriendt;Annette S. Kim;Gert Mathijs;Suzanna G M Frints

  • Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia

    Kim De Keersmaecker;Zeynep Kalender Atak;Ning Li;Carmen Vicente

  • Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast.

    Carlos Graux;Jan Cools;Lucienne Michaux;Peter Vandenberghe

  • CD80, CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model.

    Stefaan W. Van Gool;Peter Vandenberghe;Mark de Boer;Jan L. Ceuppens

  • A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL)

    Konstantinos J Mavrakis;Joni Van der Meulen;Andrew L Wolfe;Andrew L Wolfe;Xiaoping Liu

  • Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia

    Idoya Lahortiga;Kim De Keersmaecker;Kim De Keersmaecker;Pieter Van Vlierberghe;Carlos Graux;Carlos Graux;Carlos Graux

  • Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia

    Yilong Li;Claire Schwab;Sarra L. Ryan;Elli Papaemmanuil

  • Clinical, Molecular, and Prognostic Significance of WHO Type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and Various Other 3q Abnormalities in Acute Myeloid Leukemia

    Sanne Lugthart;Stefan Gröschel;H. Berna Beverloo;Sabine Kayser

  • Mucormycosis in allogeneic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis.

    J Maertens;Hilde Demuynck;Eric Verbeken;P Zachée

  • Duplication of the MYB oncogene in T-cell acute lymphoblastic leukemia

    Idoya Lahortiga;Kim De Keersmaecker;Pieter Van Vlierberghe;C. Graux

Frequent Co-Authors

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring the field of Medicine in the USA often means looking into related online degrees and alternative pathways to a healthcare career. Many students consider nursing as a direct and rewarding route. For those seeking affordability, you can find some of the cheapest online bsn programs that offer flexibility while keeping tuition costs low. These programs are ideal for working registered nurses looking to advance without a major financial burden.

If you’re not a nurse but want to move into advanced practice quickly, pursuing a direct entry msn online can be a fast-track option. These innovative programs allow individuals from non-nursing backgrounds to earn a master’s in nursing and qualify for higher-level roles.

Admission competitiveness is a key concern for many students. Some direct admit nursing programs offer less restrictive entry requirements, making it easier to start your nursing education journey.

Additionally, for those interested in healthcare administration, medical billing and coding is a practical choice. Many wonder, can you get financial aid for medical billing and coding programs? The answer is yes—financial aid is available for many accredited online schools, making this pathway even more accessible.

Best Scientists Citing Peter Vandenberghe

Trending Scientists